(Q42545724)

English

A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease

scientific article published on January 1998

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

cystic fibrosis

0 references

author name string

Lindblad A

1

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Glaumann H

2

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Strandvik B

3

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

language of work or name

0 references

publication date

1 January 1998

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

166-174

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Hepatobiliary disease in cystic fibrosis: a survey of current issues and concepts

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270126

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatic changes in young infants with cystic fibrosis: Possible relation to focal biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270126

7 January 2021

based on heuristic

inferred from DOI database lookup

Liver disease and common-bile-duct stenosis in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270126

7 January 2021

based on heuristic

inferred from DOI database lookup

Sclerosing cholangitis in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270126

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of bile acid therapy for gallstone dissolution: a meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270126

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of ursodeoxycholic acid (UDCA) on serum liver damage indices in patients with chronic active hepatitis. A double-blind controlled study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270126

7 January 2021

based on heuristic

inferred from DOI database lookup

A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270126

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of ursodeoxycholic acid on serum enzymes and liver histology in patients with chronic active hepatitis. A 12-month double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270126

7 January 2021

based on heuristic

inferred from DOI database lookup

Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270126

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of ursodeoxycholic acid treatment on nutrition and liver function in patients with cystic fibrosis and longstanding cholestasis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270126

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of ursodeoxycholic acid on liver function in patients with cystic fibrosis and chronic cholestasis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270126

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270126

7 January 2021

based on heuristic

inferred from DOI database lookup

Scintigraphic documentation of an improvement in hepatobiliary excretory function after treatment with ursodeoxycholic acid in patients with cystic fibrosis and associated liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270126

7 January 2021

based on heuristic

inferred from DOI database lookup

A simple method for determination of antipyrine clearance

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270126

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of the hepatic galactose elimination capacity after a single intravenous injection in man: the reproducibility and the influence of uneven distribution

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270126

7 January 2021

based on heuristic

inferred from DOI database lookup

The major metabolites of ursodeoxycholic acid in human urine are conjugated with N-acetylglucosamine

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270126

7 January 2021

based on heuristic

inferred from DOI database lookup

Conjugation types of 7 beta-hydroxylated bile acids detected in healthy human urine

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270126

7 January 2021

based on heuristic

inferred from DOI database lookup

Morphological findings in the liver of children with cystic fibrosis: a light and electron microscopical study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270126

7 January 2021

based on heuristic

inferred from DOI database lookup

Abnormal urinary bile acids in a patient suffering from cerebrotendinous xanthomatosis during oral administration of ursodeoxycholic acid

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270126

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of liver disease in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270126

7 January 2021

based on heuristic

inferred from DOI database lookup

Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270126

7 January 2021

based on heuristic

inferred from DOI database lookup

Ursodeoxycholic acid therapy in cystic fibrosis-associated liver disease: a dose-response study.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270126

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of ursodeoxycholic acid after 4 to 12 years of therapy in early and late stages of primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270126

7 January 2021

based on heuristic

inferred from DOI database lookup

Excretion of bile acids in healthy children and children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270126

7 January 2021

based on heuristic

inferred from DOI database lookup

The fecal microflora and bile acids in children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270126

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced microbial transformation of bile acids in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270126

7 January 2021

based on heuristic

inferred from DOI database lookup

Urinary bile acid excretion in correlation to liver histopathology in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270126

7 January 2021

based on heuristic

inferred from DOI database lookup

Bile acid profiles in urine of patients with liver diseases

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270126

7 January 2021

based on heuristic

inferred from DOI database lookup

Heterologous expression of delta F508 CFTR results in decreased sialylation of membrane glycoconjugates

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270126

7 January 2021

based on heuristic

inferred from DOI database lookup

Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270126

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270126

7 January 2021

based on heuristic

inferred from DOI database lookup

Biotransformation of orally administered ursodeoxycholic acid in man as observed in gallbladder bile, serum and urine

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270126

7 January 2021

based on heuristic

inferred from DOI database lookup

Liver cirrhosis in cystic fibrosis--therapeutic implications and long term follow up.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270126

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunomodulatory effects of ursodeoxycholic acid on immune responses

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270126

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacology of ursodeoxycholic acid, an enterohepatic drug.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270126

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.510270126

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42545724&oldid=1961302092"